{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:35:15Z","timestamp":1789576515496,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102311","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:11:34Z","timestamp":1743027094000},"page":"102311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Netarsudil-associated conjunctival pigmentation"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6498-8329","authenticated-orcid":false,"given":"Soufiane","family":"Azargui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Karanxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3654-6502","authenticated-orcid":false,"given":"Scott CN.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik Y.","family":"Kahook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5784-0022","authenticated-orcid":false,"given":"Cara E.","family":"Capitena Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2025.102311_bib1","first-page":"887","article-title":"Glaucoma is second leading cause of blindness globally","volume":"82","author":"Kingman","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102311_bib2","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1177\/11206721211008783","article-title":"Netarsudil: a new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension","volume":"31","author":"Batra","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2025.102311_bib3","first-page":"2112","article-title":"The effects of netarsudil ophthalmic solution on aqueous humor dynamics in humans","volume":"58","author":"Sit","year":"2017","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2025.102311_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/jop.2017.0023","article-title":"Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma","volume":"34","author":"Lin","year":"2018","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.ajoc.2025.102311_bib5","first-page":"111","article-title":"Novel pharmacologic candidates for treatment of primary open-angle glaucoma","volume":"90","author":"Lu","year":"2017","journal-title":"Yale J Biol Med"},{"issue":"8","key":"10.1016\/j.ajoc.2025.102311_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/1060028020971215","article-title":"Netarsudil for the treatment of open-angle glaucoma and ocular hypertension: a literature review","volume":"55","author":"Gonzalez","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.ajoc.2025.102311_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/IJG.0000000000001634","article-title":"Pooled efficacy and safety profile of netarsudil ophthalmic solution 0.02% in patients with open-angle glaucoma or ocular hypertension","volume":"29","author":"Singh","year":"2020","journal-title":"J Glaucoma"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102311_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10792-021-02002-w","article-title":"Status of Rho kinase inhibitors in glaucoma therapeutics\u2014an overview","volume":"42","author":"Saha","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102311_bib9","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/IJG.0000000000001636","article-title":"Reticular epithelial edema: an uncommon side effect of ROCK\/NET inhibitor netarsudil","volume":"29","author":"Chen","year":"2020","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajoc.2025.102311_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2020.04.002","article-title":"Reticular bullous epithelial edema in corneas treated with netarsudil: a case series","author":"Wisely","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102311_bib11","first-page":"43","article-title":"Rho kinase\/norepinephrine transporter inhibition for the treatment of glaucoma and ocular hypertension","author":"Bacharach","year":"2016","journal-title":"Glaucoma Today"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102311_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ophtha.2014.08.022","article-title":"Double-masked, randomized, dose- response study of AR-13324 (netarsudil) versus latanoprost in patients with elevated intraocular pressure","volume":"122","author":"Bacharach","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102311_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"ROCKET-1 and ROCKET-2 study groups. two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated iop treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102311_bib14","series-title":"Aerie Pharmaceticals Roclatan\u2122 Mercury Phase 3 Topline Efficacy Results Conference Call","author":"Aerie Pharmaceuticals","year":"2017"},{"key":"10.1016\/j.ajoc.2025.102311_bib15","article-title":"Netarsudil-associated epithelial keratopathy","volume":"19","author":"Ramakrishnan","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2025.102311_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-021-02665-0","article-title":"Rhopressa-induced corneal edema: a case report","volume":"15","author":"Chu","year":"2021","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.ajoc.2025.102311_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2024.102069","article-title":"Crystalline keratopathy following long-term netarsudil therapy","author":"Cummings","year":"2024","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2025.102311_bib18","first-page":"61","article-title":"Primary acquired melanosis of the conjunctiva: experience with 311 eyes","volume":"105","author":"Shields","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102311_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0161-6420(84)34245-2","article-title":"Conjunctival melanosis and melanoma","volume":"91","author":"Folberg","year":"1984","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102311_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.survophthal.2003.10.008","article-title":"Tumors of the conjunctiva and cornea","volume":"49","author":"Shields","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102311_bib21","series-title":"Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Textbook","first-page":"307","article-title":"Conjunctival melanocytic lesions","author":"Shields","year":"2016"},{"key":"10.1016\/j.ajoc.2025.102311_bib22","series-title":"Rhopressa (Netarsudil Ophthalmic Solution) 0.02%: FDA Advisory Committee Briefing Document","year":"2017"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102311_bib23","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","volume":"53","author":"Alm","year":"2008","journal-title":"Surv Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:27:28Z","timestamp":1760146048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":23,"alternative-id":["S2451993625000647"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102311","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Netarsudil-associated conjunctival pigmentation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102311"}}